Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  12/05/2008
 
Trade Name:  Arimidex
 
Generic or Proper Name (*):  anastrozole
 
Indications Studied:  Male pubertal patients with gynecomastia and female pediatric patients with McCune-Albright syndrome with progressive precocious puberty
 
Therapeutic Category:  Estrogen lowering agent
 
Ages Studied:  10 years and older
 
Study #:  2
 
Study Type:  Efficacy/Safety
 
Study Design:  Open Label
 
No Patients:  28
 
No Centers:  14
 
No Countries:  7
 
BPCA(B), PREA(P):  B
 
Asian:  1
 
Black:  0
 
Other:  1
 
White:  26
 
Native Hawaiian or Pacific Islander:  0
 
American Indian/Alaska Native:  0
 
Hispanic/Latino:  0
 
Non-Hispanic/Non Latino:  0
 
-
-